Biolife Solutions (BLFS) Depreciation & Amortization (CF) (2010 - 2026)

Biolife Solutions (BLFS) has 17 years of Depreciation & Amortization (CF) data on file, last reported at $374000.0 in Q1 2026.

• Depreciation & Amortization (CF) for Q1 2026 came in at $374000.0, down 45.16% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.9 million (down 56.57% YoY), and the FY2025 annual result was $2.3 million, down 56.34% from the prior year.
• Depreciation & Amortization (CF) grew to $374000.0 in Q1 2026 per BLFS's latest filing, from $261000.0 in the prior quarter.
• Over five years, Depreciation & Amortization (CF) peaked at $2.0 million in Q2 2023 and troughed at $261000.0 in Q4 2025.
• A 5-year average of $1.3 million and a median of $1.5 million in 2024 frame the typical range for Depreciation & Amortization (CF).
• The sharpest annual moves came in 2022 and 2025: Depreciation & Amortization (CF) surged 112.74% in 2022, then tumbled 72.15% in 2025.
• A 5-year view of Depreciation & Amortization (CF) shows it stood at $1.7 million in 2022, then slipped by 14.6% to $1.5 million in 2023, then plunged by 36.17% to $937000.0 in 2024, then plunged by 72.15% to $261000.0 in 2025, then soared by 43.3% to $374000.0 in 2026.
• Business Quant data shows BLFS's Depreciation & Amortization (CF) at $374000.0 in Q1 2026, $261000.0 in Q4 2025, and $636000.0 in Q3 2025.